Orphan Drugs & Rare Diseases Global Congress 2018 Europe is planned to start on 07 Mar and end on 09 Mar 2018.
Orphan Drugs & Rare Diseases Global Europe 2018 will be in London, UK but the venue of the event hasn’t been determined yet.
The preeminent event in Pharmaceutical category will be the center of attention of Rare Diseases, Drug Development, Drug Delivery and Orphan Drugs matters.
Orphan Drugs & Rare Diseases Global Europe 2018 is organized annually.
The organizer of the Orphan Drugs & Rare Diseases Global Europe 2018, Orphan Drugs & Rare Diseases Global Congress 2018 Europe is Paradigm Global Events.
When you are in London for Orphan Drugs & Rare Diseases Global Europe 2018, consider these three must visit locations and adore the beauty of this city:
This year’s congress will look into Practical strategies and best practices on challenges, innovations, technologies and concepts surrounding orphan drugs and rare diseases. There are more than 7,000 rare diseases identified, however, only a fraction of them have approve treatment available. “Orphan drugs” are intended to treat diseases so rare that sponsors are reluctant to develop them under usual marketing conditions. Currently, the regulatory climate is favourable with both FDA and European Medicines Agency, as they offer incentives, tax credits, user waivers and marketing exclusivity. As a result, the number of therapies approved for rare diseases for the past two decades has grown exponentially. The 3-day Congress will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organisations, orphan drugs developers as well as regional and loc
- Orphan Drugs & Rare Diseases 2016
- Hilton London Kensington
14 - 16 March 2016